年龄只是一个数字吗? 在TAILORx后的时代,型DX测试和化疗使用
Ashely Aller1, Shiyun Zhu2, Liisa Lyon2
1Department of Hematology and Oncology, Northwest Medical Specialties, Tacoma, Washington, USA.
Cancer
|December 12, 2025
概括
在TAILORx后的时代,瘤型DX (ODX) 测试增加,特别是在年轻的患者中. 然而,ODX测试可以通过ODX测试.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 临床试验 临床试验
背景情况:
- TAILORx试验显著影响了瘤型DX (ODX) 早期乳腺癌风险分层.
- 本研究研究了ODX在TAILORx后的化疗决策中的实际临床使用.
研究的目的:
- 分析早期乳腺癌患者的ODX测试和化疗使用趋势.
- 调查患者人口统计学,特别是年龄,对ODX测试和治疗决策的影响.
主要方法:
- 从2015年到2021年,对8017名乳腺癌早期患者进行了回顾性分析.
- 多变量后勤回归用于识别与ODX测试和化疗相关的因素.
- 考克兰-阿米塔奇测试,以评估ODX测试的趋势随着时间的推移.
主要成果:
- ODX测试率从2015年的45%大幅上升至2021年的80%.
- 每年化疗使用量增加约5% (aOR,1.05).
- 年轻的患者更有可能接受ODX测试,但测试与年轻个体的化疗少,老年患者的化疗更多相关.
结论:
- 年龄较小是推动后TAILORx时代增加ODX测试的关键因素.
- 在ODX测试和化疗建议之间的关系是年龄相关的.
- 年龄显著影响ODX测试模式和化疗利用,需要进一步调查.
更多相关视频
10:10Long-term Culture of Human Breast Cancer Specimens and Their Analysis Using Optical Projection Tomography
Published on: July 29, 2011
15.7K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
14.3K
相关概念视频
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
